AC Immune SA reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported net loss was CHF 19.64 million compared to CHF 19.07 million a year ago. Basic loss per share from continuing operations was CHF 0.23 compared to CHF 0.26 a year ago.
For the six months, net loss was CHF 38.49 million compared to CHF 35.8 million a year ago. Basic loss per share from continuing operations was CHF 0.46 compared to CHF 0.5 a year ago.